Structure Therapeutics (GPCR) EPS (Weighted Average and Diluted) (2022 - 2026)
Quarterly EPS (Weighted Average and Diluted) fell 29.63% to -$0.35 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$0.88 through Mar 2026, down 1.15% year-over-year, with the annual reading at -$0.8 for FY2025, 2.56% down from the prior year.
Structure Therapeutics' EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.35 for Q1 2026.
- EPS (Weighted Average and Diluted) came in at -$0.35 for Q1 2026, down from $0.2 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.2 in Q4 2025 to a low of -$1.64 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.25 (2023), against an average of -$0.49.
- The largest YoY upside for EPS (Weighted Average and Diluted) was 190.91% in 2025 against a maximum downside of 100.0% in 2025.
- Structure Therapeutics' EPS (Weighted Average and Diluted) stood at -$1.17 in 2022, then surged by 86.32% to -$0.16 in 2023, then crashed by 37.5% to -$0.22 in 2024, then surged by 190.91% to $0.2 in 2025, then tumbled by 275.0% to -$0.35 in 2026.
- Per Business Quant, the three most recent readings for GPCR's EPS (Weighted Average and Diluted) are -$0.35 (Q1 2026), $0.2 (Q4 2025), and -$0.37 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.02 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.75 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.51 |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -1.17 |
| Sep 30, 2022 | -1.27 |
| Jun 30, 2022 | -1.64 |
| Mar 31, 2022 | -1.44 |